Thousands of cancer patients in England to benefit from new immunotherapy jab

Thousands of cancer patients in England will benefit from a new immunotherapy treatment called pembrolizumab, which can treat several types of cancer and be administered in under two minutes. The NHS announced this new treatment, which kills cancer cells by blocking a protein called PD-1. This allows the immune system to recognise and attack cancer cells.